Glenmark Pharma Gets US Health Regulator's Nod for Prostate Cancer Treatment Drug in Top Business News- News18.com published on October 16, 2019 leave a reply Quoting IQVIA sales data for the 12 month period ending August 2019, Glenmark said the Zytiga tablets, 250 mg market achieved annual sales of approximately USD 794.1 million. from Top Business News- News18.com https://ift.tt/2VMehmz Tweet Share Share Share Share Previous Post Despite IMF Projection of 6% Growth, India Still Among Fastest-growing Economies: Sitharaman Next Post GSSSB Clerk and Office Assistant New Admit Card 2019 Released @ojas.gujarat.gov.in, Download OJAS Admit Card post written by: Rohit Related PostsAstraZeneca Sells Former Blockbuster Cholesterol Drug For $320 MillionAstraZeneca said on Tuesday it would sell rights to its erstwhile blockbuster cholesterol drug, Crestor, to German pharmaceutical company Gruenenthal GmbH for a… Continue ReadingBrexit Is Still Stuck As EU Is Being Unfair, UK SaysBrexit trade talks are still stuck on fishing, governance rules and dispute resolution because the European Union is asking too much, British Prime Minister Bor… Continue ReadingVolkswagen Faces Leadership Crisis As CEO Demands Vote Of ConfidenceVolkswagen, the world's largest vehicle maker by sales, risked a leadership crisis on Tuesday after Chief Executive Herbert Diess forced a vote of confidence in… Continue ReadingIs Shopping In Stores Safe During The Pandemic?Is shopping in stores safe during the pandemic? from Top Business News- News18.com https://ift.tt/37D7SR5 … Continue ReadingAstraZeneca Sells Cholesterol Drug Rights To Grünenthal For $320 MillionAstraZeneca said on Tuesday it would sell rights to its cholesterol drug, Crestor, to German pharmaceutical company Grünenthal GmbH for an upfront payment of $3… Continue Reading
0 comments: